CVS Health Corporation (CVS)


NYSE - NYSE Real Time Price. Currency in USD
97.17-0.10 (-0.10%)
At close: 4:02 PM EDT
People also watch:
COSTRADUNHTGTCL
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open97.05
Prev Close97.27
Bid94.50 x 300
Ask97.70 x 100
Day's Range96.96 - 98.09
52wk Range86.50 - 106.67
1y Target EstN/A
Market Cap103.6B
P/E Ratio (ttm)22.35
Beta0.88
Volume3,434,512
Avg Vol (3m)4,893,034
Dividend & Yield1.70 (1.75%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Why PharMerica Soared 13.4% Today
    Motley Fool11 hours ago

    Why PharMerica Soared 13.4% Today

    Rumors that the company may be exploring a sale sparked investor enthusiasm.

  • Market Realist2 days ago

    Did Target’s Fiscal 2Q16 Same-Store Sales Growth Meet Guidance?

    In fiscal 2Q16, Target’s (TGT) comparable same-store sales growth declined to 1.1%. However, same-store sales were in the middle of prior guidance of -2%–0%.

  • PR Newswire3 days ago

    CVS Health Research Institute Study Shows Value in Tailoring Medication Adherence Interventions to Specific Patient Populations

    WOONSOCKET, R.I., Aug. 22, 2016 /PRNewswire/ -- A new study from the CVS Health Research Institute found that interventions to keep patients with common chronic conditions adherent  is extraordinarily cost-effective. The study, published today in The American Journal of Managed Care, also found an even greater opportunity for cost-savings if medication adherence resources are focused on patients with three or more chronic co-morbidities, such as hypertension, diabetes and high cholesterol. "There is extensive evidence supporting the relationship between better adherence, improved health outcomes and reduced health care costs, but efforts to improve medication adherence, while effective, can be costly," said Troyen A. Brennan, M.D., Chief Medical Officer of CVS Health.